パセオン List of News Articles

Gene therapy, particularly modalities using AAV, is garnering significant expectations; however, the high manufacturing costs and challenges in scaling up present major obstacles to practical application. In this seminar, we will introduce practical approaches to optimize costs and development timelines while maintaining high quality, based on insights gained from supporting numerous projects as a global CDMO. On the day of the event, in addition to presentations by experts active at the forefront globally, we will have a panel discussion featuring Kazunobu Oyama, Executive Officer of Onodera GT Pharma, a Japanese biotech venture developing gene therapies, and Sota Yoshizawa, also an Executive Officer. They will discuss a wide range of topics, including the challenges currently faced in the development and manufacturing of viral vectors and regulatory compliance. Event Overview Date: April 24, 2026 (Friday) 15:00-18:00 (Registration starts at 14:30) Location: Thermo Fisher Scientific Japan Group Regenerative Medicine Creative Experience Lab (Shibaura, Tokyo) Pre-registration is required (limited capacity). Please apply through the Paseon site.

We will be exhibiting at CPhI Japan 2026, which will be held at Tokyo Big Sight from April 21 to 23, 2026. 【Exhibitor Presentations】 April 21 (Tuesday) 14:00 - 14:30 1B-04 Changing the Norms of rAAV Manufacturing: Cost Innovation Realized through Automation and Scalable Development April 21 (Wednesday) 16:00 - 16:30 1C-06 What Makes a Preferred Injectable? — The Shortest Path to Commercial Success through Patient-Centric Format Selection April 22 (Wednesday) 15:00 - 15:30 1C-11 Utilizing AI/ML to Enhance Quality, Speed, and Efficiency in Pharmaceutical Formulation Development — Perspectives and Experiences from a Global CDMO April 22 (Wednesday) 16:00 - 16:30 1C-12 Biopharmaceutical Manufacturing Strategies Aimed at Commercialization — A Roadmap to Success through Technology Transfer, Scaling, and Supply Optimization April 23 (Wednesday) 10:30 - 11:00 1B-13 Evolving GMP Analytical Strategies: Rapid Development Capability, Unwavering Regulatory Compliance, and Expanding Global Scalability If you would like to request a meeting, please contact us via the link below.